Clinical Trial Update: Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing Onyx and TRUFILL for brain arteriovenous malformations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Arteriovenous Malformations

Drugs mentioned

• Onyx (ethylene-vinyl alcohol copolymer (EVOH) embolic agent)
• TRUfill

Snippet

Sponsor: Medtronic Neurovascular Clinical Affairs | Conditions: Brain Arteriovenous Malformations | Phase 2 | Status: COMPLETED